XBI

redditmytit

This will be minimum $10 by end of year. Currently in shares and options. Volume patters on the quarterly chart are absolutely bonkers. $XBI is heating up fast af boi. G’luck.

Tradingland

Market rotation is under way. From tech to health care. XBI perked up. SPRO SGMT PROK ready to moon.

MyStrategicForecast

XBI. Lots of premium that doesn't align with the volatility.

tachyonvelocity

XBI exposure, when the news of pharma tariffs happened, sold a bunch of puts, which turned into 15k gains. Then used that to buy picks and shovels and some specific names. Now I have XBI, IQV, ICLR, REGN, BIO, BRKR, AVTR, EXAS, ILMN, also many big biotech.

tachyonvelocity

The “safe” stocks here are actually unprofitable biotech, like XBI, because the benefit they get from rate cuts are more than losses from employment spending.

_foundation

You know this shit is weird when XBI is ripping on the daily.

andytobbles

Current positions - leaps on XBI, AMD, GLD, WMT, XLV. Full defense with a splash of AMD

Three_of_a_kind3515

WTF… QQQ should be flying.. XBI should tank with 🥭 telling them to lower drug costs in our America.. and, well JOBY.. flying cars.. reminds me of Back to the Future.. (side bar.. Toyota bought a large percentage of the shares as well recently) https://preview.redd.it/mgvp5h6hq9gf1.jpeg?width=1170&format=pjpg&auto=webp&s=fc961e12ea0609b524bd22bac0a1054811dbe3ed

Three_of_a_kind3515

WTF… QQQ should be flying.. XBI should tank with 🥭 telling them to lower drug costs in our America.. and, well JOBY.. flying cars.. reminds me of Back to the Future.. (side bar.. Toyota bought a large percentage of the shares as well recently)

mofosombo

XBI

DoubleFamous5751

I’m buying XBI and BAX on Monday

Any-Inspection-3325

congrats to all who have heed our call to sell semis and rotate into defensives and small caps, enjoy ur big gains later! we are intending to bring QQQ down to .7-.9% along with SMH -2% while rotating to XLV XHB XBI and consumer defensives

slie911

IWM and XBI both got destroyed today. There is often a correlation so I would imagine there was just risk off sell programs happening

PM_STOCKS_TO_BUY

yeah I can also trade sector specific which is decent like SMH, XBI etc… but not as freeeing as individual stocks. Keep me more risk averse at least!

Any-Inspection-3325

protect urself just for this week, keep ur profits and rotate to KHC PG CL BRKB CPB STZ CAG PEP MO XHB XBI all the smart money rotating into these stocks in the massive tech flush this week

dimethylhyperspace

7/18 on a low IV index etf will make time decay pretty negligible whther you close at 10,12 or 3. Unfortunately, its always a guess as to whether selling is the right time or the wrong time, but taking small profits every day is absolutely the right way to do it. Alot of times, Ill decide what I hope to make off an option, and set a sell order for it, right after I buy it. Then I let the market decide. Id be lying if I told you holding is better than selling. You just dont know, and never will. But alot of times, moreso than not, if it's up in the am, itll be up a bit more around the close. But not always lol. There will be no IV crush because there is no binary news event for the XBI on the horizon.

Master-Ebb9786

Grabbed an XBI $88c for 7/18 Wish me luck! (Was that dumb?) 

dimethylhyperspace

Z I haven't bought anything yet..spreads on Zillow are pretty bad. Probably going ATM calls on XBI and at the money puts on Citigroup. Both for 7/18

dimethylhyperspace

Plays for tommorrow: Calls on Zillow, XBI, MSTR(if you like high risk) Puts: Citigroup

tachyonvelocity

Pharmaceutical tariffs are a complete nothingburger. After it was announced yesterday, today XBI is up over 3%. Merck 15%, PFE 18% off the lows. Pharma companies have high margins, even 200% on imports are not going to affect bottom line much. Pharma also has pricing power and people would rather stop spending on discretionary items than pharmaceuticals. The proposed tariffs give way too long a runway for pharma companies to onshore, over a year, by which time, the tariffs become politically tenuous. To me tariffs are an obvious political tool by one person, Trump. If he gets out, then most tariffs are gone. Now, obviously this won't happen for some time, but the most affected stocks that survive, and I expect all big pharma, and related service companies to, will be good long term investments.

dimethylhyperspace

Biotech is breaking out. Might buy calls on XBI

Pin-Last

Spot on. Hoping my google, TSM, and AVGO, & MRVL can do the same.     If you bought XBI at 65 and sold at 90 every time for the last 9 years, you beat every ETF out there except SMH (by a *hair*). I do stuff like that too, lets me stay in cash usually, rn at 4.5% interest. 

Pin-Last

I’m in healthcare for a trade, temporarily my largest combined “position” thru BIB, IBB, CURE, XBI

MagJack

my AI overlord says: Turning $250K into $1 million is ambitious—but absolutely possible with the right mix of strategy, time, and risk tolerance. Let’s break down a few realistic paths someone could take, depending on how fast they want to get there and how much risk they’re willing to stomach: 🧠 Option 1: The Long Game (10–15 Years) - Approach: Invest in a diversified portfolio of broad-market ETFs like VTI, QQQ, or SCHG. - Expected Return: ~8–10% annually (historical average) - Outcome: At 10% annual growth, $250K becomes $1M in ~15 years. - Risk: Moderate. Market volatility, but historically reliable over time. ⚡ Option 2: Accelerated Growth (5–10 Years) - Approach: Tilt toward high-growth sectors like tech (SMH, AIQ), clean energy (QCLN), or biotech (XBI). - Expected Return: 12–15% annually (with higher volatility) - Outcome: $250K could 4x in 8–9 years if trends hold. - Risk: Higher. Sector-specific downturns can delay or derail progress. 🎯 Option 3: Aggressive Strategy (3–5 Years) - Approach: Mix of individual high-growth stocks, 0DTE options, or leveraged ETFs like TQQQ or SOXL. - Expected Return: Potentially 25–40%+ annually—but highly variable. - Outcome: $250K could hit $1M in 3–4 years, but with serious drawdown risk. - Risk: Very high. One bad year could cut the portfolio in half. 🏘️ Bonus Option: Real Estate or Business - Approach: Use $250K as a down payment on income-generating property or seed capital for a business. - Upside: Leverage and cash flow can accelerate returns. - Risk: Depends on execution, market, and management. If this were a real scenario, I’d suggest building a tiered plan: anchor with stable ETFs, layer in some growth, and carve out a small slice for high-risk/high-reward plays. Want to sketch out a sample portfolio or timeline based on one of these paths?

BermudopeHighangle

Rotating from SPY and VTI into XBI Biotech ETF (most undervalued ETF today)

BermudopeHighangle

XBI, COPX, SILJ etfs will outperform SPY for the next year

leomeng

XBI

sneakpeekbot

Here's a sneak peek of /r/wallstreet using the [top posts](https://np.reddit.com/r/wallstreet/top/?sort=top&t=year) of the year! \#1: ["The Power Of Flow & Frequency" - $XBI](https://i.redd.it/f4p96rmj9trd1.jpeg) | [1 comment](https://np.reddit.com/r/wallstreet/comments/1fsefsi/the_power_of_flow_frequency_xbi/) \#2: [Tesla (NASDAQ: TSLA) Stock Soars Amid China FSD Approval Buzz Following Elon Musk’s Surprise Visit](https://abbonews.com/us-markets/tesla-nasdaq-tsla-stock-soars-amid-china-fsd-approval-buzz-following-elon-musks-surprise-visit/) | [1 comment](https://np.reddit.com/r/wallstreet/comments/1ch2xni/tesla_nasdaq_tsla_stock_soars_amid_china_fsd/) \#3: [Early entry time](https://i.redd.it/db1q8i5y6g3d1.jpeg) | [8 comments](https://np.reddit.com/r/wallstreet/comments/1d3pjm6/early_entry_time/) ---- ^^I'm ^^a ^^bot, ^^beep ^^boop ^^| ^^Downvote ^^to ^^remove ^^| ^^[Contact](https://www.reddit.com/message/compose/?to=sneakpeekbot) ^^| ^^[Info](https://np.reddit.com/r/sneakpeekbot/) ^^| ^^[Opt-out](https://np.reddit.com/r/sneakpeekbot/comments/o8wk1r/blacklist_ix/) ^^| ^^[GitHub](https://github.com/ghnr/sneakpeekbot)

tachyonvelocity

Sold XBI puts when it was 77 for 10k, now I don’t even want to see biotech stocks go up nearing expiration. If XBI goes back down to 70s, it’s time to start longs again. Biotech stocks are just completely washed out, like 08 level crash, from high interest rates, pharma tariffs, govt science funding cuts, sentiment is the worst it’s been in a couple decades. But that’s the opportunity.

thegabe101

The funniest shit by far rn is XBI being green when our authoritarian government is threatening to evaporate half of biotech profits 

imdaviddunn

Well, that’s one way to get people to ignore your tariffs in the short term. R.I.P IBB/XBI

Equivalent-Stop7266

$XBI puts should print since pharma is fucked

XXX_KimJongUn_XXX

XBI got fucked up today lmao

longlurke

What happened to XBI? Why did it die so quick all of a sudden?

XXX_KimJongUn_XXX

XBI crashing, -6%, high volume.

Short-Taro-5156

>If he's going to sell calls on unh I'd sell them itm as a way to exit. Selling calls in general is a losing strategy. I'd avoid it as much as possible but if he decides he wants to I'd agree. >I think target and wal mart are both going to be in some pain in the months ahead. Consumer debt really can't handle much more pressure and consumer confidence is just not there. That's why I suggested a long TGT/short WMT trade. WMT is near its highs on declining margins w/ meager growth. Target has seen a small drop in revenue but if the consumer is tapping out both will see a decline and WMT is likely to fall much more given the sky high valuation. TGT doesn't look terrible here as a long on fundamentals but the consumer is certainly shaky. That being said, the stock is down almost 40% since the election, so it would appear that is being priced in to an extent. Either way absolutely a long relative to WMT imo given similar consumer exposure and diverging valuations >I also wouldn't touch LLY or most biotech, especially right now, due to its reliance on medical trials. Unless you can properly hedge the downside or take a defined risk position that you're comfortable with. The hedge to the downside risk is the valuation of these companies. Your view is the consensus: don't touch biotech. Hence why XBI is at 2017 levels. I've found that when everyone can agree directionally on something it tends to be mispriced. That being said I agree that any single early stage biotech name has massive binary risk. The sector as a whole has immense uncertainty surrounding it and given historically low valuations is a reasonable sector to consider a position in for a swing in sentiment. >Mercado Libre is worth noting though since you talked about Mexico and Latin America. Agree this will probably do well on LatAm flows but I'm not a fan of the valuation -- valued like a US company in a LatAM market and feel there are much more compelling options if one wants to choose a single name in Brazil. I'd rather own something like INTR at 16x trailing earnings w/ similar revenue growth to MELI and a larger growth runway

BeerPowered

Healthcare or cybersecurity look good right now less hype than AI but strong growth potential. For healthcare, check XBI or ISRG. For cybersecurity, CIBR ETF or CRWD. Energy isn't saturated either with all these data centers uranium plays like CCJ might be worth a look.

SpectacularRedditor

She said short XBI. And short the dollar. And short the USA. Curisously, she said go long penis pills. Not sure if that was a directed attack or not.

Flipside68

XBI is down 55% since 2021 ARKG is down 80% Biotech needs a resurgence. I believe the reds will move on some health stuff soon after this Tarriff mess blows over. So might be a year or two out still

stocksNblondz

Wild. $XBI had some nice flow Friday, maybe with tariff news this weekend we’ll see some money flow back into these beat up biotechs. Otherwise private equity is going to start to gobble them up and take them private

f00dl3

Because in certain sectors (i.e. Bitcoin, Russel 2000) it did last that long. Actually, XBI and IWM never even recovered. They are still ... shit. XBI will probably remain terrible until RFK is out.

LeonMarmaduke

For the love of god, please don’t do this until you research 3x leveraged ETF’s. It is meant to be a short term play (weeks is a long hold) because the fees and decay (with it being 3x) would kill you long term. Price of these over time gets down to single digits and they reset at a higher price via reverse split to make it tradable for swings and options. See 3x long of XBI is LABU, 3x long of UNG is BOIL etc

androidmj

1. Earnings Reports & Corporate Updates (Q1 & Q2 2025) – These will give insight into Capricor’s financial runway, commercialization readiness, and any FDA interactions. Look for updates on manufacturing scale-up and potential milestone payments. 2. Advisory Committee (AdCom) Meeting Decision – If the FDA doesn’t schedule an AdCom, it’s a bullish sign that they don’t see major issues. If they do, it means more scrutiny and volatility. 3. FDA Communications – If the company drops any PR about FDA interactions (e.g., no major questions, streamlined review), that could boost sentiment. 4. Short Interest & Borrow Rate Trends – If shorts start covering ahead of PDUFA, it could indicate shifting sentiment. 5. Institutional Buying – If funds/hedges start entering, it could signal confidence in approval. 6. Broader Biotech Market – If sentiment in biotech improves (XBI running), CAPR could get tailwinds. If no AdCom is scheduled and earnings show solid execution, adding before run-up season (June-July) might be a strategy. If AdCom happens, expect volatility but also an opportunity if the panel leans positive.

tachyonvelocity

pharma is also cyclical, in relation to interest rates. When IR is high, why would investors take high risks for negative returns now and potential returns many years later? You could just as well put money in a 30-yr bond and get 4.5%. So you get biotech boom during covid zero IR, and now a pretty big downcycle when IR is close to 5%. Is this the bottom? Biotech (XBI) already priced in high inflation and high IR in crashes during 2022 and 2023. Biotech services (CROs like ICLR/IQV, DHR, and not WST) are pricing in this slowdown. So we're definitely closer to the bottom than the top.

leomeng

What? I never liked the guy and initial XBI reaction was negative

leomeng

Look at the candle on XBI

Overthehill410

It funds preclinical crap. Most of actual clinical studies is funded by bag holders of XBI.

leomeng

XBI rallying

Kochina-0430

Is XBI worth buying with yield at 0.14 and expense ratio at 0.35?

prabin96

good luck. hope JPow comes with Tenet hat on.. I had some XBI 120s for March but the day after I bought, some news came related to Kennedy’s plans for healthcare and whole biotech sector took a noise dive.. I am expecting a turnaround of biotech in 2025 so placing a bet on XBI via options. and have been adding like a maniac lol

Externox

Thank you for the advice I’m just cruising 🤞🏻 that before Friday it could go somewhere so I can least sell but not in deep water , last week did a pump that I didn’t have no gain or losses either I couldn’t sell but since I was in area with no internet i couldn’t sell I found out later in the afternoon about the pump 😫😢….. and between you doing option with XBI?

prabin96

never play biotech/health care options.. First they are illiquid af and second some FDA approval type shits are announced outta nowhere and stock dumps by 80%. (telling this whilst holding $XBI leaps that are -50% )

______deleted__

XBI and LABU have fucked me up. I should have went into AI instead of bumfuck biotech

consciouscreentime

TQQQ and other leveraged ETFs decay over time, making them unsuitable for wheeling. High IV Rank *is* important. Look at non-leveraged ETFs with high IVR like XBI (Biotech), IWM (Russell 2000), or KWEB (China Internet). [Tastytrade](https://tastytrade.com/) has good resources on wheeling mechanics. [Option Alpha](https://www.optionalpha.com/) also has some solid educational content.

Limp-Confidence2920

https://youtu.be/vaUTXa9c9CY?si=Ma5io_7QdHZ0XBI7

figlu

Pump has not actually begun yet, the rise from bottom was just recovery with XBI. Wait for gap up. My avg on the 03/25 5s were 0.35. They were as low as 0.25s when sp was around 2.8 the lowest point

Meakmoney1

XBI biotech ripping harder! Smalls also

Meakmoney1

Does XBI continue its bounce

Meakmoney1

Watching XBI rebound🚀🚀

Unlucky-Prize

Small cap biotech is in the dumpster, XBI captures a lot of that. There are good reasons for it though, but it’s got a lot of companies trading under cash value with good IP…

Stonkgang_

Still have faith, that XBI sell off from the JFK news was not ideal though lol. Holding and no reason to sell for me

Dat-Boi-6122

Good lord, I just noticed how badly muh biotech (XBI) got decimated by RFK....

A_Smart_Scholar

LABU or XBI, the entire biotech has been decimated from this news. LABU is down 40% just this week.

_foldLeft

Yolod into too many stupid memes earlier this week and been paying for it. XBI a disaster

thestashman23

XBI go boom soon

ntovi

VKTX will, assuredly, open at $100 tomorrow and then will skyrocket. Any shares that you can purchase below $110 will be profitable If VKTX IV crushes and pares gains it's a certainty that I will be buying that dip with gratitude. It is a gift from heaven above. VKTX will moon to 200 dollars a share through acquisition pressure from big bois like Merck. # My positions - **11/15 calls with 80, 90, 100, 120, and 130 strikes (selling most at $110 price actions tomorrow)** **100 shares LONG and rapidly adding to my port. anything under 100 is worth grabbing for now** # Related plays/ideas \-Short subpar biopharm competitors like Novo, Tern, & Alt \-Long weight-loss and BIO ETFS - lets leverage. OZEM, LABU, XBI

______deleted__

XBI. It’s the biotech ETF. When rates go down, biotech investment goes up. One of AI’s biggest applications is in molecular dynamics (a la Alphafold). Or be like me and have almost 2 year’s worth of salary in its 3x leveraged version, LABU.

NewVanilla2251

Half in IWM half in XBI

The-Night-Raven

$XBI

gliamastrr

Look for undervalued growth machines and put all ur $ into them every week. Example of undervalued growth machines: SQ, SHOP, SE, CART (e-commerce); TSLA, SMCI, GOOGL (AI), XBI (SNP biotech)

Desmater

Still trading CELH and LUNR. TLT and XBI too.

DanielBandview

november is the month of science XBI 

Pin-Last

Oh ABR is PERFECT for this. Thanks! XBI has been range bound for most of the last decade. I play it from both sides using a fade-in strategy I cooked up. LABU long, LABD short.  If you just bought XBI @65 and sold @90, rinse/repeat, you’d be up 700% in the last 9 years. That’s long/unleveraged only. 700%. 

AsAboveSoBelow322

April 19 Positive Inflow Of $237 Million June 25 Positive Inflow Of $555 Million September 24 Positive Inflow Of $297 Million A Spike In Positive Flow = $XBI RALLIES BY 11%

AsAboveSoBelow322

April 19 Positive Inflow Of $237 Million June 25 Positive Inflow Of $555 Million September 24 Positive Inflow Of $297 Million A Spike In Positive Flow = $XBI RALLIES BY 11%

pineapplekiwipen

XBI ripping 👀

WillisTalking17

XBI may be the dumbest chart I have ever seen

Desmater

Yes, XBI and LABU might be good plays. But go long, like shares, sell puts or buy leaps. No short term, October can be red.

Stonkgang_

No way, 30% short against an ETF is outrageous and those options are juicy cheap. XBI will greatly lag in comparison.

WillisTalking17

XBI 😙

sick_economics

XBI is the definition of small cap growth.... In that it is made up exclusively of young and risky names in the biotech space. They're basically all small cap companies, all hoping to be growth companies and they share many of the same characteristics that you would find in a small cap growth fund.

Imaginary_Eye_8349

XBI and IWM look the most bullish. ALL IN ALL IN all in my $100 allowance.

Imaginary_Eye_8349

Will change my mind tmr. Brb. Actually some setups look bullish. XBI TSLA IWM But SPY has double tiny gap downs yet to fill. FOMC is bullish day tho. sigh...

Pin-Last

We’re supposed to track all 5 companies daily? If you bought the biotech etf, XBI, every time it hit 65 and sold every time it hit 90, you made 7x in the last 10 years. 700% initial principal. Hell of a lot easier to fact check and (btw) to execute.

Winning--Bigly

You're implying that XBI is a good investment (and being up 83% is indeed a good return, i'm not denying that), but just having invested in any low cost SPY fund would've had an even better return, with less stress and worry. and a much simpler strategy.

Winning--Bigly

I just went and took a Quick Look on Apple stock app. Over the last 10 years XBI is up 83%. SPY is up 175%

dvdmovie1

They changed the index methodology this Summer so it now emphasizes large caps more but otherwise, could you have traded the range in XBI over the last 10 years or so? Sure. Will that continue to work going forward? Who knows.

spacecadet501st

Bullish for XBI

Pin-Last

If you just bought small cap biotech with XBI every time it hit 65 and sold every time it hits 90, you’d have a 700% gain over the last decade. 

Pin-Last

If you just bought XBI, smaller biotech, at 65 and sold at 90… you’d be up 700% in the last decade. That’s yummy bio trading.

Pin-Last

Buy the small cap biotech etf, XBI, at 65 and sell at 90, do nothing else… ur up 700% over the last 10 years.

Blazzck7

XBI don’t miss it

Blazzck7

XBI setting up

Pin-Last

When GDXJ gets low enough I use a quant strategy to buy bigger and bigger bites of JNUG, a leveraged GDXJ derivative, as it drops. People call it a “mushroom” strategy sometimes, so it’s profitable way before it gets to where you started buying. Same with utilities, UTSL when XLU drops low enough. LABU for biotech too, from XBI, all industries that must necessarily recover assuming no zombies. Currently also in BTG gold miner for the div and recovery potential. And mushrooming into LABD rn, a short biotech ETF, XBI is getting overbought. And buy VALE, 13% div and big recovery potential. 

GreyMatter22

I am leveraged to the tits in IWM, RSP, ASTS, RIVN, XBI and NVDA. Gotta diversify both streams few months out.

Pin-Last

My thoughts too. Rates are still historically very high and rate sensitize stuff has really been popping, I’m actually building an XBI (biotech) short with LABD. For longs, Brazil is cheap with huge divs, VALE, RIO, EWZ. I like S. Korea and Mexico here too. 

Pin-Last

We’ve already seen a lot of bounce off the falling rates sentiment, I just started building a quant short strategy with LABD, on this premise. Wait for the dip in these sectors (XBI for small cap biotech or LABU for real juice, REITs, TLT, etc) and buy in. For now the rates sentiment hasn’t really saved S. America, so RIO, VALE, EWZ, low prices and huge divs will draw back investors. S. Korea too for international, so EWY. Good luck and if you want to be a rotate your portfolio guy, remember to rotate your portfolio out too!

Florida_Man0101

You can stick with XBI. You will notice it does not correlate with SPY. You may get lucky with a few small labs, but big money is in weight loss drugs also lipid technology.

Meakmoney1

XBI on the menu bois

UnsweetIceT

XBI and call it a day